10x Genomics, Inc. (TXG)
NASDAQ: TXG · Real-Time Price · USD
20.91
+0.10 (0.48%)
At close: Mar 9, 2026, 4:00 PM EDT
20.86
-0.05 (-0.24%)
After-hours: Mar 9, 2026, 5:12 PM EDT

10x Genomics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Market Capitalization
2,6712,0641,7386,6154,17116,640
Upgrade
Market Cap Growth
88.94%18.74%-73.72%58.59%-74.93%9.21%
Upgrade
Enterprise Value
2,2161,6691,4266,3573,81516,120
Upgrade
Last Close Price
20.8116.3114.3655.9636.44148.96
Upgrade
PS Ratio
4.133.212.8510.698.0833.92
Upgrade
PB Ratio
3.342.592.458.935.1820.35
Upgrade
P/TBV Ratio
3.642.832.529.195.3621.13
Upgrade
P/FCF Ratio
20.4015.86----
Upgrade
P/OCF Ratio
19.5115.17260.86---
Upgrade
EV/Sales Ratio
3.452.602.3410.277.3932.86
Upgrade
EV/FCF Ratio
17.0312.83----
Upgrade
Debt / Equity Ratio
0.110.110.120.130.120.10
Upgrade
Debt / FCF Ratio
0.650.65----
Upgrade
Net Debt / Equity Ratio
-0.55-0.55-0.44-0.40-0.42-0.62
Upgrade
Net Debt / EBITDA Ratio
6.856.851.971.792.4215.90
Upgrade
Net Debt / FCF Ratio
-3.37-3.3754.254.602.034.12
Upgrade
Asset Turnover
0.660.660.650.620.500.50
Upgrade
Inventory Turnover
2.852.852.502.701.701.65
Upgrade
Quick Ratio
3.953.954.103.964.086.10
Upgrade
Current Ratio
4.464.464.974.694.856.77
Upgrade
Return on Equity (ROE)
-5.78%-5.78%-25.17%-32.98%-20.45%-7.48%
Upgrade
Return on Assets (ROA)
-6.40%-6.40%-12.84%-12.52%-9.99%-3.40%
Upgrade
Return on Capital Employed (ROCE)
-11.30%-11.30%-24.20%-23.80%-18.20%-5.80%
Upgrade
Earnings Yield
-1.64%-2.11%-10.51%-3.86%-3.98%-0.35%
Upgrade
FCF Yield
4.90%6.30%-0.33%-0.96%-3.96%-0.74%
Upgrade
Buyback Yield / Dilution
-3.57%-3.57%-2.80%-2.90%-3.18%-9.09%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.